TFF Pharmaceuticals Inc. (TFFP): Total Asset Value of Company

Graphic logo of TFF Pharma (TFFP)

The daily price chart for TFF Pharmaceuticals (TFFP) currently reflects a level of 10.98. Management is transparently executing the company's wind-down procedure and the sale of intellectual property rights due to a capital shortage. The asset liquidation process and the cessation of all R&D follow the termination of work on the innovative drug drying method. Previously, the business relied on a thin-film freezing platform to create unique inhalation formulations.

TFF Pharmaceuticals (TFFP) Company Total Assets: for the period 07/04/2022 - 12/21/2024

Comprehensive metric breakdowns and analytics for TFF Pharma (TFFP)

- price and consensus price forecast:
Quote Chart tffpharma.com|TFFP - Price Target Chart
- market capitalization data:
Market Valuation TFF Pharmaceuticals, Inc|TFFP - Enterprise Value
- book capitalization data:
Accounting Value of a Share TFF Pharmaceuticals|TFFP - Book Capitalization|Market Capitalization to Book Value Ratio tffpharma.com|TFFP - Aggregate Company Assets
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio TFF Pharmaceuticals|TFFP - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio TFF Pharmaceuticals, Inc|TFFP - Company Aggregate Debts|Debts to Book Capitalization TFF Pharmaceuticals, Inc|TFFP - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings TFF Pharmaceuticals
Fundamental valuation:TFFP, tffpharma.com
Finished products of TFF Pharmaceuticals

Resource control is critical for building a resilient portfolio; therefore, this indicator, calculated inversely via return on assets (ROA), objectively measures the sum of equity and liabilities. Amid radical cost minimization and the transition of TFF Pharmaceuticals (TFFP) toward IT licensing, the total asset value clearly demonstrates the efficiency of balance sheet compression and the discipline of residual capital management.

Competitors of TFF Pharmaceuticals (TFFP)

HLN (haleon.com) - Total Asset Value of Company|Aggregate Company Assets Kenvue KVUE|Total Asset Value of Company Verona Pharma PLC|Jyong Biotech Corp (MENS) - Company Total Assets|Aggregate Asset Value Ligand Corp (LGND)|Company Total Assets AMRX (Amneal Pharmaceuticals)|perrigo.com - Company Total Assets|Aggregate Company Assets Alvotech SA (ALVO)|LQDA: Aggregate Asset Value|GLPG (Galapagos Genomics) - Aggregate Company Assets|ANI Pharmaceuticals Corp (ANIP) - Cumulative Company Assets|MNKD (MannKind Corporation) - Company Total Assets|Company Total Assets amphastar.com (AMPH)|Pacira BioSciences, Inc. (PCRX) - Cumulative Company Assets|Aggregate Asset Value SPRY (ARS Pharmaceuticals Inc)|TBPH: Aggregate Company Assets|AQST - Company Assets|Cumulative Company Assets scPharma SCPH|TECX - Aggregate Business Assets|Company Total Assets Tonix Pharmaceuticals Holding Corp. TNXP|China SXT Pharmaceuticals, Inc. (SXTC) - Aggregate Asset Value|Company Total Assets EPRX (Eupraxia Pharmaceuticals, Inc.)|Company Assets BHST|eXoZymes Inc (EXOZ) - Aggregate Company Assets|Aggregate Asset Value oramed.com ORMP|Cumulative Company Assets Entera Bio (ENTX)|Aggregate Business Assets MindWalk Holdings, Inc. HYFT|Company Total Assets ABVC BioPharma Inc|CPIX - Total Asset Value of Company|Company Total Assets Quantum BioPharma Ltd (QNTM)|Total Asset Value of Company fibrogen.com|TELO - Cumulative Company Assets|Aggregate Asset Value RANI|SNYR - Aggregate Company Assets|Total Asset Value of Company rallybio.com (RLYB)|Company Total Assets Lexaria Bioscience Corp.|Aggregate Asset Value pulmatrix.com PULM|Pheton - Company Total Assets|APM: Company Total Assets|Aggregate Company Assets Lyra Therapeutics, Inc LYRA|IBO (Impact BioMedical, Inc.) - Aggregate Asset Value|Aggregate Company Assets TNFA|Cumulative Company Assets cbdMD Corp|Company Total Assets PRFX|Company Total Assets altamiratherapeutics.com (CYTO)|Lipella - Company Total Assets|Cumulative Company Assets OptiNose Corp OPTN|PIRS (Pieris Pharmaceuticals) - Company Total Assets|procapsgroup.com (PROC) - Company Assets|PTPI: Cumulative Company Assets|Company Total Assets Qilian International Holding Group|ACELYRIN, Inc. (SLRN) - Cumulative Company Assets